Treatment Discontinuation Patterns for Patients with CLL in the Real-World Settings: Results from a Multi-Center Study

被引：0

作者：

Shadman, Mazyar ^{[1
]}

Sail, Kavita ^{[2
]}

Manzoor, Beenish S. ^{[2
]}

Yazdy, Maryam Sarraf ^{[3
]}

Hill, Brian T. ^{[4
]}

Tuncer, Hande H. ^{[5
]}

Allan, John N. ^{[6
]}

Ujjani, Chaitra S. ^{[1
]}

Emechebe, Nnadozie ^{[2
]}

Kamalakar, Rajesh ^{[2
]}

Sharmokh, Simon ^{[2
]}

Jiang, Daniel Dingfeng ^{[2
]}

Pena, German ^{[2
]}

Marshall, Thomas ^{[2
]}

Nielsen, Jacqueline ^{[2
]}

Barr, Paul M. ^{[7
]}

Brown, Jennifer R. ^{[8
]}

Schuh, Anna ^{[9
]}

Eyre, Toby A. ^{[9
]}

Lamanna, Nicole ^{[10
]}

Wierda, William G. ^{[11
]}

Skarbnik, Alan ^{[12
]}

Roeker, Lindsey E. ^{[13
]}

Bannerji, Rajat ^{[14
]}

Pauff, James M. ^{[2
]}

Schuster, Stephen J. ^{[15
]}

Follows, George A. ^{[16
]}

Cheson, Bruce D. ^{[17
]}

Eichhorst, Barbara F. ^{[18
]}

Brander, Danielle M. ^{[19
]}

Pivneva, Irina ^{[20
]}

Guerin, Annie ^{[20
]}

Mato, Anthony R. ^{[13
,21
]}

机构：

[1] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA

[2] AbbVie Inc, N Chicago, IL USA

[3] Georgetown Univ Hosp, Washington, DC 20007 USA

[4] Cleveland Clin, Cleveland, OH 44106 USA

[5] Lowell Gen Hosp, Ctr Canc, Lowell, MA USA

[6] Weill Cornell Med Univ, Med Ctr, New York, NY USA

[7] Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY 14642 USA

[8] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[9] Oxford Univ Hosp NHS Fdn Trust, Churchill Hosp, Oxford, England

[10] Columbia Univ, New York, NY USA

[11] MD Anderson Canc Ctr, Houston, TX USA

[12] Novant Hlth, Charlotte, NC USA

[13] Mem Sloan Kettering Canc Ctr, Div Hematol Oncol, CLL Program, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA

[14] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA

[15] Univ Penn, Lymphoma Program, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[16] Cambridge Univ Hosp NHS Trust, Cambridge, England

[17] Georgetown Univ Hosp, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

[18] Univ Cologne, Dept Internal Med, Ctr Integrated Oncol Koln Bonn, Cologne, Germany

[19] Duke Univ, Med Ctr, Duke Canc Ctr, Durham, NC USA

[20] Anal Grp, Montreal, PQ, Canada

[21] Mem Sloan Kettering Canc Ctr, Hematol Malignancies Div, CLL Program, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-131401

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3048

引用

页数：7

共 50 条

[21] Real-world treatment patterns and clinical outcomes in EGFR-mutant locally advanced lung adenocarcinoma: A multi-center cohort study
Bi, Nan
Xu, Kunpeng
Ge, Hong
Chen, Ming
Mingyan, E.
Zhang, Li
Cao, Jianzhong
Zhang, Xu
Ding, Xiao
Xia, Bing
Zhao, Lujun
Han, Lijie
Li, Jiancheng
Hu, Chen
Wang, Luhua
JOURNAL OF THE NATIONAL CANCER CENTER, 2023, 3 (01): : 65 - 71
[22] Characteristics of patients treated for CLL in a real-world registry: results from informCLL™
Mato, Anthony
Sharman, Jeff
Pagel, John
Brander, Danielle
Kadish, Karen
Tomlinson, Brian
Ipe, David
Yang, Huiying
Arango-Hisijara, Israel
Srivastava, Bhavini
Schenkel, Brad
Barrientos, Jacqueline
LEUKEMIA & LYMPHOMA, 2017, 58 : 48 - 49
[23] CORONARY SINUS NARROWING FOR THE TREATMENT OF REFRACTORY ANGINA: RESULTS FROM THE REDUCER-I MULTI-CENTER REAL-WORLD CLINICAL TRIAL
Verheye, Stefan
van de Hoef, Tim P.
de Silva, Ranil
Van Kuijk, Jan Peter
Byrne, Jonathan
Montorfano, Matteo
Buschmann, Eva
Dupont, Matthias
Banai, Shmuel
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 802 - 802
[24] Favorable Outcomes in CLL Pts with Alternate Kinase Inhibitors Following Ibrutinib or Idelalisib Discontinuation: Results from a Large Multi-Center Study
Mato, Anthony
Nabhan, Chadi
Barr, Paul M.
Ujjani, Chaitra S.
Hill, Brian T.
Lamanna, Nicole
Skarbnik, Alan P.
Howlett, Christina
Pu, Jeffrey J.
Sehgal, Alison R.
Strelec, Lauren E.
Vandegrift, Alexandra
Rago, Allison
Zent, Clive S.
Feldman, Tatyana
Goy, Andre
Claxton, David F.
Bachow, Spencer Henick
Kaur, Gurbakhash
Svoboda, Jakub
Nasta, Sunita Dwivedy
Porter, David
Landsburg, Daniel J.
Schuster, Stephen J.
Cheson, Bruce D.
Evens, Andrew M.
BLOOD, 2015, 126 (23)
[25] Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis
Caputo, Roberta
Buono, Giuseppe
Piezzo, Michela
Martinelli, Claudia
Cianniello, Daniela
Rizzo, Alessandro
Pantano, Francesco
Staropoli, Nicoletta
Cangiano, Rodolfo
Turano, Salvatore
Paris, Ida
Nuzzo, Francesco
Fabi, Alessandra
De Laurentiis, Michelino
FRONTIERS IN ONCOLOGY, 2024, 14
[26] A real-world study on the treatment of extremely preterm infants: a multi-center study in southwest area of Fujian Province in China
Gao, Liang
Chen, Dong-mei
Yan, Hui-ping
Xu, Li-ping
Dai, Shu-zhen
Zhong, Rong-hua
Chen, Qi-bing
Ma, Si-min
Lin, Xin-zhu
BMC PEDIATRICS, 2024, 24 (01)
[27] REAL-WORLD EFFECTIVENESS AND SAFETY OF TOFACITINIB IN CROHN'S DISEASE: A MULTI-CENTER STUDY
Fenster, Marc
Khatiwada, Aava
Wang, Wenfei
Dimopoulos, Christina
Hirten, Robert
Gutierrez, Alexandra
Colombel, Jean Frederic
Cohen, Benjamin
Ciorba, Matthew A.
Rubin, David T.
Ungaro, Ryan C.
Pekow, Joel R.
Deepak, Parakkal
GASTROENTEROLOGY, 2020, 158 (06) : S1211 - S1211
[28] Real-world clinical analysis in 190 advanced NSCLC patients with uncommon EGFR mutations: A multi-center study
Qin, Yi
Long, Yaling
Tang, Yuan
Tian, Yuke
Li, Juan
Duan, Ping
Luo, Jieyan
Yu, Min
Li, Yanying
Zhou, Xiaojuan
Wang, Ke
Gong, Youling
Peng, Feng
Zhu, Jiang
Liu, Yongmei
Zhou, Lin
Lu, You
Huang, Meijuan
CANCER SCIENCE, 2023, 114 (06) : 2552 - 2559
[29] Clinical outcomes and therapeutic modalities in older Chinese patients with MCL: a multi-center real-world retrospective study
Yang, Yuan
Yang, Ping
Zhang, Wei
Liu, Hui
Sun, Xiuhua
Xiao, Xiubin
Wang, Jingwen
Li, Zhenling
Li, Lihong
Wang, Shuye
He, Juan
Li, Xiaoling
Cai, Qingqing
Zhang, Weilong
Wang, Jing
Li, Chunyuan
Chen, Yingtong
Liu, Shuozi
Jing, Hongmei
ANNALS OF MEDICINE, 2025, 57 (01)
[30] Prevalence, clinical characteristics, and treatment outcomes of patients with BRAF-mutated advanced NSCLC in China: A real-world multi-center study
Jia, B.
Zhao, J.
Jin, B.
Zhang, F.
Wang, S.
Zhang, L.
Wang, Z.
An, T.
Wang, Y.
Zhuo, M.
Li, J.
Yang, X.
Li, S.
Chen, H.
Chi, Y.
Wang, J.
Zhai, X.
Tai, Y.
Liu, Y.
Guan, G.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S61 - S61

← 1 2 3 4 5 →